The competitive inhibition of amine oxidase with special reference to the carcinoid syndrome.
D000818:Animals; D004837:Epinephrine / Q000494:pharmacology*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000494:pharmacology*; D008303:Malignant Carcinoid Syndrome / Q000378:metabolism*; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology*; D009647:Normetanephrine / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000494:pharmacology*; D014556:Urine
D008996:Monoamine Oxidase Inhibitors; D009647:Normetanephrine; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D008995:Monoamine Oxidase; D009638:Norepinephrine; D004837:Epinephrine